---
title: 'Research Daily Summary: What Happened on November 19, 2026'
headline: UCLA researchers restore gene activity in autism models
description: Other teams used AI to design functional RNA and identify genomic features
  resembling CRISPR.
url: https://thebench.bio/news/research/2026-11-19
topic: research
date: '2026-11-19'
covers:
- '2026-11-19'
date_published: '2026-11-19T12:03:58Z'
date_modified: '2026-11-19T12:03:58Z'
tags:
- Industry
- Software
sources: 3
publisher: TheBench.Bio
---

# Research Daily Summary: What Happened on November 19, 2026

**UCLA researchers restore gene activity in autism models**

Other teams used AI to design functional RNA and identify genomic features resembling CRISPR.

## Today in brief

UCLA researchers used CRISPR activation to boost two autism-risk genes in neuronal cells and brain organoids. [1] In separate studies, researchers used AI to design functional RNA, and Anthropic scientists said AI agents found genomic features resembling CRISPR. [2] [3]

## CRISPR activation restored gene activity in autism models

UCLA researchers used enhancer-targeted CRISPR activation to boost CHD8 and SCN2A expression in neuronal cells and brain organoids. [1] In CHD8 models, the intervention brought activity closer to typical levels, supported normal cell maturation and reduced abnormal organoid growth. [1]

In SCN2A models, it largely restored normal neuronal electrical activity, although some details remained impaired in certain cell lines. [1] Expression rose in mutant models but not in healthy cells. Researchers intervened 25 days into CHD8 organoid development and 100 days into SCN2A development. [1]

The findings come from cell and organoid models, not clinical testing. [1] Study first author George Chen said delivery and timing require substantial further study before the approach could be used clinically. [1]

## Also worth knowing

- RhoAgent, an AI system for designing and refining functional RNA, produced active ribozymes with 40–70% sequence similarity to their natural counterparts. It improved one ribozyme’s cleavage efficiency by up to sixfold versus a construct shortened by human experts, and produced an aptamer scaffold with 230% greater fluorescence than the natural version. [2]
- Anthropic scientists said AI agents found repeat arrays beside specific proteins in genomic regions resembling CRISPR. One protein was predicted to be a reverse transcriptase, while the other’s function remained unclear. [3]

## The day in numbers

- **Up to sixfold**: Increase in cleavage efficiency for the hovlinc ribozyme compared with a construct shortened by human experts. [2]
- **230%**: Greater fluorescence from the AI-designed aptamer scaffold than from the wild-type aptamer. [2]

## Also published

- [Author Correction: Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study](<https://www.nature.com/articles/s41591-026-04803-x>), Nature Medicine

## Sources

1. [CRISPR-A, organoids and autism: searching for a potential preventative](<https://www.biotechniques.com/neuroscience/crispr-a-organoids-and-autism-searching-for-a-potential-preventative/>), BioTechniques, 2026-11-19
2. [Programmable functional RNA design with a virtual scientist](<https://www.nature.com/articles/s41587-026-03362-3>), Nature Biotechnology, 2026-11-19
3. [Anyone, Anywhere Can Be An Experimental Biochemist](<https://omicsomics.blogspot.com/feeds/3554501453185509151/comments/default>), Omics! Omics!, 2026-11-19

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.biotechniques.com/neuroscience/crispr-a-organoids-and-autism-searching-for-a-potential-preventative/>
[2]: <https://www.nature.com/articles/s41587-026-03362-3>
[3]: <https://omicsomics.blogspot.com/feeds/3554501453185509151/comments/default>
